Select Experience
Medicus Pharma, (TSXV: MDCX; NASDAQ: MDCX), in its US IPO and NASDAQ-listing
Pharmascience in successfully defending nine class actions in four jurisdictions across Canada related to alleged impurities in pharmaceutical products
Dr. Reddy's Laboratories Canada and Pharmascience in a proposed class action in the Federal Court alleging industry-wide price fixing and market allocation of generic drugs
Bard/Becton, Dickinson and Company and Davol in the defence of multiple class actions and more than 200 individual mass tort product liability actions relating to hernia mesh
Apotex in two class actions in British Columbia concerning alleged nitrosamine impurities in pharmaceutical products, including losartan and amitriptyline
Mimi's Rock in its $30-million acquisition by FitLife Brands by way of plan of arrangement as well as ongoing corporate, M&A, securities, real estate and governance advice
Seagen, as Canadian competition counsel, in its US$43-billion acquisition by Pfizer
A multinational specialty biopharmaceutical company in providing regulatory advice related to its drug and medical device products. We routinely advise on licensing, packaging and labelling, distribution, advertising and sale requirements
A biotechnology company in its product liability matters in Canada
Amgen in 5 patent infringement actions involving six different patents initiated by plaintiffs Bayer and Regeneron Pharmaceuticals relating to the drug EYLEA®
Amgen in a judicial review proceeding initiated by Bayer Inc. relating to the timing of listing patents on the patent register
Amgen Canada in patent litigation brought by Alexion Pharmaceuticals, and in related patent impeachment proceedings, relating to SOLIRIS® (eculizumab)
Medicus Pharma in its recent Canadian listing, establishment of a US$50-million shelf prospectus with the Ontario Securities Commission, and proposed US listing
A global fashion and lifestyle retailer in providing regulatory advice related to the approval, sale and advertisement of cosmetics and medical devices consistent with the client's commercial goals
Breathe Biomedical in its proposed listing on NASDAQ and TSX
Reunion Neuroscience in its acquisition and take-private transaction with MPM BioImpact
Mustgrow Biologics in a joint venture with Bayer to develop sustainable organic biologicals in Europe, Asia Pacific, Middle East and Africa
Briacell Therapeutics in the spin-out of BriaPro Therapeutics Corp
Bloom Burton & Co. and Haywood Securities in a US$150-million private placement of common shares of Cybin
Solve FSHD Holdings as lead investor with Cambrian Biopharma in Vita Therapeutics' US$31-million Series B equity financing
Cantor Fitzgerald Canada Corporation in an up to US$35-million at-the-market equity program for the sale of common shares pursuant to an equity distribution agreement with Cybin (NEO: CYBN) (NYSE American: CYBN)
MustGrow Biologics in connection with the filing of a base shelf prospectus relating to the offering for sale, from time to time, of common shares, warrants, units, debt securities, subscription receipts or any combination thereof for aggregate gross proceeds of up to $40 million
Stifel Nicolaus Canada in the $2.8-million overnight marketed offering of Mydecine Innovations Group
MustGrow Biologics in its non-brokered private placement for gross proceeds of $7.1 million
A syndicate of underwriters, co-led by Leede Jones Gable, in the $8.1-million bought-deal public offering of units of Ventripoint Diagnostics
Skandinaviska Enskilda Banken AB (publ) as joint lead arranger and joint bookrunner in term loan facilities totalling $385 million and $125 million revolving credit facility made to a corporation in the medical technology industry
United Active Living in matters related to ownership and operations of assisting living housing projects
Kensington Capital Partners and Kensington Private Equity Fund in the $35-million acquisition and related financing through its portfolio company, Clearpoint Health Network, of the surgical and medical centres business of Centric Health Corporation, a TSX listed company, and subsequent reorganization of Clearpoint